Sep 07, 2015 - straZeneca (AZN) inks a drug delivery technology deal with Starpharma Holdings Limited for the development of oncology compounds.
Sep 04, 2015 - AstraZeneca (AZN) gained FDA approval for a new 60 mg dose for the treatment of patients with a history of heart attack beyond the first year.
Sep 03, 2015 - AstraZeneca (AZN) signs up with Daiichi Sankyo for FluMist Quadrivalent in Japan; reports positive phase III data on antibiotic drug CAZ-AVI.
Sep 03, 2015 - Nektar (NKTR) received milestone payment of $40 million from AstraZeneca (AZN) for the first commercial sale of Moventig in EU.
Sep 02, 2015 - AstraZeneca (AZN) strikes a collaboration agreement with Valeant for the development and commercialization of brodalumab.
Aug 28, 2015 - Eli Lilly (LLY) announced that the FDA has approved its diabetes drug, Synjardy, for the treatment of patients with type II diabetes.
Aug 25, 2015 - Medivation (MDVN) enters into an asset purchase agreement with BioMarin to acquire worldwide rights to BioMarin's talazoparib.
Aug 25, 2015 - AstraZeneca (AZN) inked a clinical trial collaboration with Peregrine to evaluate bavituximab plus durvalumab in a phase I/Ib study.